Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, Inc. (SRPT), sold 29,900 shares at $123.10 ($3.7M) on 2024-03-08, disclosed to the SEC on 2024-03-11.
Seasonal sale ($3.7M) by Director — this insider has traded SRPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.39 | 100 | $12K | 0.3% |
| 2 | $123.10 | 11,745 | $1.4M | 39.2% |
| 3 | $123.10 | 11,745 | $1.4M | 39.2% |
| 4 | $123.85 | 3,155 | $391K | 10.6% |
| 5 | $123.85 | 3,155 | $391K | 10.6% |
| Total | $123.26 avg | 29,900 |
| $3.7M |
| 100% |
| Filing → |
| SRPT | SELL | 2021-03-10 | $835K | — | Filing → |
| SRPT | SELL | 2020-08-11 | $3.2M | — | Filing → |
| SRPT | SELL | 2020-05-22 | $1.2M | — | Filing → |